Hologic News (NASDAQ:HOLX)

DateTimeSource
Headline
07/05/20174:01PMPRNUSHologic to Announce Financial Results for the Third Quarter of Fiscal 2017 on Wednesday, August 2, 2017
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2017 on Wednesday, August 2, 2017 PR Newswire MARLBOROUGH, Mass., July 5, 2017 MARLBOROUGH, Mass., July 5, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter... More...>>
07/03/20171:00PMPRNUSHologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert PR Newswire MARLBOROUGH, Mass., July 3, 2017 MARLBOROUGH, Mass., July 3, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior... More...>>
06/29/20178:00AMPRNUSHologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe
Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe PR Newswire MARLBOROUGH, Massachusetts, June 29, 2017 -- New Panther Fusion® Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory MARLBOROUGH, Massachusetts, June 29, 2017 /PRNewswire/... More...>>
06/20/20178:00AMPRNUSHologic Announces FDA Clearance of Aptima® Assay to Detect Herpes Simplex Virus 1 & 2
Hologic Announces FDA Clearance of Aptima® Assay to Detect Herpes Simplex Virus 1 & 2 -- Aptima HSV 1 & 2 Assay Now Available Alongside Women's Health, Virology Menu on the Fully Automated Panther System -- PR Newswire MARLBOROUGH, Mass., June 20, 2017 MARLBOROUGH, Mass. , June 20, 2017 /PRNewswire/ -- Hologic... More...>>
06/15/20178:00AMPRNUSHologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure® for Non-Invasive Body Contouring (Lipolysis) ...
Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure® for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs SculpSure Now Cleared to Treat Five Areas of the Body PR Newswire MARLBOROUGH, Mass., June 15, 2017 MARLBOROUGH, Mass., June 15, 2017 /PRNewswire/ -- Hologic, Inc... More...>>
06/07/20178:00AMPRNUSFDA Approves Hologic's Genius™ 3D Mammography™ Exam as the Only Mammogram Superior for Women with Dense Breasts*
FDA Approves Hologic's Genius™ 3D Mammography™ Exam as the Only Mammogram Superior for Women with Dense Breasts* --Genius exam improves cancer detection and reduces recall rates for women of all ages and breast types, including the nearly 50 percent of women of breast cancer screening age who have dense breasts-- --Separate... More...>>
05/16/20174:01PMPRNUSCharles J. Dockendorff Elected to Hologic Board of Directors
Charles J. Dockendorff Elected to Hologic Board of Directors PR Newswire MARLBOROUGH, Mass., May 16, 2017 MARLBOROUGH, Mass., May 16, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that Charles J. Dockendorff has been elected to the Company's Board of Directors, effective immediately.  Mr. Dockendorff... More...>>
05/10/20174:03PMPRNUSHologic Announces Financial Results for Second Quarter of Fiscal 2017
Hologic Announces Financial Results for Second Quarter of Fiscal 2017 -- GAAP Diluted EPS of $1.84 Increases 666.7%, Non-GAAP Diluted EPS of $0.50 Increases 6.4% -- -- Revenue of $715.4 Million Grows 3.2%, 3.8% in Constant Currency -- -- Base Business Revenue, Net of Acquisitions and Divestitures, Grows 4.7%, 5.4% in Constant... More...>>
05/08/20174:01PMPRNUSHologic to Webcast Presentations at Upcoming Investor Conferences
Hologic to Webcast Presentations at Upcoming Investor Conferences PR Newswire MARLBOROUGH, Mass., May 8, 2017 MARLBOROUGH, Mass., May 8, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: Bank of America Merrill Lynch 2017 Health Care... More...>>
04/04/20174:01PMPRNUSHologic to Announce Financial Results for the Second Quarter of Fiscal 2017 on Wednesday, May 10, 2017
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2017 on Wednesday, May 10, 2017 PR Newswire MARLBOROUGH, Mass., April 4, 2017 MARLBOROUGH, Mass., April 4, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter... More...>>
04/03/20174:01PMPRNUSHologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert PR Newswire MARLBOROUGH, Mass., April 3, 2017 MARLBOROUGH, Mass., April 3, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior... More...>>
03/22/20176:10PMPRNUSPenn National Gaming Set to Join S&P SmallCap 600
Penn National Gaming Set to Join S&P SmallCap 600 PR Newswire NEW YORK, March 22, 2017 NEW YORK, March 22, 2017 /PRNewswire/ -- Penn National Gaming Inc. (NASD: PENN) will replace Cynosure Inc. (NASD: CYNO) in the S&P SmallCap 600 effective prior to the open on Monday, March 27. S&P 500 constituent Hologic... More...>>
03/22/20179:00AMPRNUSHologic Completes Acquisition of Cynosure
Hologic Completes Acquisition of Cynosure -- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate -- PR Newswire MARLBOROUGH, Mass., March 22, 2017 MARLBOROUGH, Mass., March 22, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has completed... More...>>
02/28/20174:16PMPRNUSSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Cynosure, Inc. - CYNO
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Cynosure, Inc. - CYNO PR Newswire NEW YORK, Feb. 28, 2017 NEW YORK, Feb. 28, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State... More...>>
02/15/20174:01PMPRNUSFDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay
FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system PR Newswire MARLBOROUGH, Mass., Feb. 15, 2017 MARLBOROUGH, Mass., Feb. 15, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced... More...>>
02/14/20178:00AMPRNUSHologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Tw...
Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses -Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate - -Accelerates Hologic's Top- and Bottom-Line... More...>>
02/09/20174:01PMPRNUSHologic to Webcast Presentations at Upcoming Investor Conferences
Hologic to Webcast Presentations at Upcoming Investor Conferences PR Newswire MARLBOROUGH, Mass., Feb. 9, 2017 MARLBOROUGH, Mass., Feb. 9, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The LEERINK Partners 6th Annual Global Healthcare... More...>>
02/02/20178:00AMPRNUSHologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System for the Treatment of Abnormal Uterine...
Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System for the Treatment of Abnormal Uterine Bleeding --Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use-- PR Newswire MARLBOROUGH, Mass., Feb. 2, 2017 MARLBOROUGH, Mass... More...>>
02/01/20174:01PMPRNUSHologic Announces Financial Results for First Quarter of Fiscal 2017
Hologic Announces Financial Results for First Quarter of Fiscal 2017 -- GAAP Diluted EPS of $0.30 Increases 3.4%, Non-GAAP Diluted EPS of $0.52 Increases 13.0% -- -- Revenue of $734.4 Million Grows 5.6%, 6.3% in Constant Currency -- -- Recently Completed Divestiture of Blood Screening Business to Accelerate Growth -- PR... More...>>
01/31/20174:05PMPRNUSGrifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million
Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire BARCELONA, Spain, Jan. 31, 2017 BARCELONA, Spain, Jan. 31, 2017 /PRNewswire/ --  The company consolidates a leading position of its Diagnostic Division enhancing its integration Grifols completes in record time... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:us D:20170724 22:29:57